Montelukast (Singulair) Side Effects Story – ABC Report – 5 Sept 2016
The popular asthma drug known as Montelukast or Singulair, which has been linked to cases of suicidal thoughts and depression in children. (It is normally prescribed for children aged two to 14 with frequent intermittent, mild persistent or exercise-induced asthma.)
Parents have stated they were never warned of the side-effects.
Between 2000 and December 2017, there were 167 adverse neuro-psychiatric side effects in children and adolescents taking the drug. In 2008, a 15-year old boy committed suicide after being on the drug for only 17 days.
Merck, Sharp, and Dohme (MSD) stand by the drug and state that consumer information is available via the TGA website or the MSD website.
Following a review of its safety, the Therapeutic Goods Administration has concluded that the drug’s side effects should be included in the boxes.
If you or a loved one have suffered the neuropsychiatric side effects of Montelukast (Singulair) please fell free to join the Montelukast (Singulair) Side Effects Support and Discussion Group on Facebook.
This is a great reminder to do your homework before popping anything into your mouth. There’s always two sides to a story and you need to be your own advocate as well as advocate for your loved ones.
Do not expect “authorities” to do your work for you. They are fallible humans. Nobody cares as much about you as you do. Nobody cares more about your children more than you do.
If you can’t find help or answers in one place, keep looking until you do!